COMPLETE RESPONSE

Clinical trials for COMPLETE RESPONSE explained in plain language.

Never miss a new study

Get alerted when new COMPLETE RESPONSE trials appear

Sign up with your email to follow new studies for COMPLETE RESPONSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope to delay ovarian Cancer's return in High-Risk patients

Disease control Ongoing

This large, late-stage trial is testing whether a drug called olaparib can help keep advanced ovarian cancer from coming back after initial chemotherapy. It is for women with a specific genetic change (BRCA mutation) whose cancer responded well to first treatment. The study compa…

Matched conditions: COMPLETE RESPONSE

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

COMPLETE RESPONSE

Get alerted when new COMPLETE RESPONSE trials appear

New hope to delay ovarian Cancer's return in High-Risk patients